Back to results
US 9,000,045 B2Granted
CETP activity inhibitors
AssigneeJapan Tobacco Inc.
InventorsHisashi Shinkai, Kimiya Maeda, Hiroshi Okamoto
Life of this patent
Estimating the term…
Abstract
The invention provides a compound that is a CETP activity inhibitor. The compound can increase HDL and at the same time decrease LDL through selective inhibition of CETP activity. the invention also provides for the use of the compound to prevent or treat atherosclerosis or hyperlipidemia.
Claims18
A CETP activity inhibitor comprising as an active ingredient a compound represented by formula (I):
- wherein
- R represents
- a straight chain or branched C2-10 alkenyl group;
- a halo-C1-4 lower alkyl group;
- a substituted or unsubstituted C5-8 cycloalkenyl group;
- a substituted or unsubstituted C3-10 cycloalkyl C1-10 alkyl group;
- or
- a substituted or unsubstituted 5- or 6-membered heterocyclic group having 1-3 nitrogen, oxygen, or sulfur atoms,
- X1, X2, X3, and X4 may be the same or different and represents
- a hydrogen atom;
- a halogen atom;
- a C1-4 lower alkyl group;
- a halo-C1-4 lower alkyl group;
- a C1-4 lower alkoxy group;
- a cyano group;
- a nitro group;
- an acyl group;
- or
- an aryl group,
- Y represents —SO2—, and
- Z represents a group of the formula
- wherein R, X1, X2, X3, X4, and Y are the same as described above;
- or a pharmaceutically acceptable salt thereof.
20 more elements
Dependencies are inferred from the claim text.